Harald Rau

12 Patents

• US125655252026

  IL-2 Conjugates

  ASCENDIS PHARMA ONCOLOGY DIVISION A/S

  0 cites
• US125444282026

  Controlled-release CNP Agonists with Reduced Side-effects

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US122747372025

  Pegylated Recombinant Human Growth Hormone Compounds

  Ascendis Pharma Endocrinology Division A/S

  0 cites
• US122460702025

  Hydrogel Cross-linked Hyaluronic Acid Prodrug Compositions and Methods

  Ascendis Pharma A/S

  0 cites
• US122396892025

  Controlled-release CNP Agonists with Low Initial NPR-B Activity

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US122264572025

  Dry Growth Hormone Composition Transiently Linked to a Polymer Carrier

  Ascendis Pharma Endocrinology Division A/S

  0 cites
• US121569172024

  CNP Prodrugs with Carrier Attachment at the Ring Moiety

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US121338832024

  Polymeric Hgh Prodrugs

  Ascendis Pharma Endocrinology Division A/S

  0 cites
• US120831822024

  Controlled-release CNP Agonists with Increased NEP Stability

  ASCENDIS PHARMA GROWTH DISORDERS A/S

  0 cites
• US116424152023

  Hydrogel Cross-linked Hyaluronic Acid Prodrug Compositions and Methods

  Ascendis Pharma A/S

  0 cites
• US116334872023

  Prodrugs Comprising an Aminoalkyl Glycine Linker

  ASCENDIS PHARMA A/S

  0 cites
• US115594822023

  Biodegradable Polyethylene Glycol Based Water-insoluble Hydrogels

  Ascendis Pharma A/S

  0 cites